HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bush’s Addition To 2009 Request Undermines Immediate FDA Needs – Specter

This article was originally published in The Tan Sheet

Executive Summary

Senate Appropriations Committee member Arlen Specter says President Bush's request to add $275 million to FDA's fiscal 2009 budget request undermines efforts to increase current funding

You may also be interested in...



FDA’s 2009 Funding Increase Gets First Congressional Check Mark

The House Agriculture Appropriations Subcommittee included an additional $275 million for FDA in its fiscal 2009 appropriations bill for a total of $2.1 billion in direct appropriations for the agency, which is $282 million above President Bush's budget request

Senate Appropriators Match Commissioner’s “Professional Judgment” Budget

A supplemental appropriations/war funding measure containing $275 million for FDA cleared the Senate Appropriations Committee May 15 but faces a tougher go in both the House and the White House

FDA Budget Request Leans On Proposed User Fees For Drug Safety Funding

Funding for FDA's drug safety programs would receive a boost from user fees under President Bush's fiscal 2009 budget request, allowing the Center for Drug Evaluation and Research to hire an additional 283 full-time staff, for a total of 2,820

Related Content

Topics

UsernamePublicRestriction

Register

WI964834

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel